These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10047503)

  • 21. Lead-oriented synthesis: a new opportunity for synthetic chemistry.
    Nadin A; Hattotuwagama C; Churcher I
    Angew Chem Int Ed Engl; 2012 Jan; 51(5):1114-22. PubMed ID: 22271624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug metabolism and pharmacokinetics in support of drug design.
    Tang W; Lu AY
    Curr Pharm Des; 2009; 15(19):2170-83. PubMed ID: 19601821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combinatorial drug discovery: which methods will produce the greatest value?
    Ecker DJ; Crooke ST
    Biotechnology (N Y); 1995 Apr; 13(4):351-60. PubMed ID: 9634776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of SHAPES screening in drug discovery.
    Lepre CA; Peng J; Fejzo J; Abdul-Manan N; Pocas J; Jacobs M; Xie X; Moore JM
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):583-90. PubMed ID: 12470255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent development and application of virtual screening in drug discovery: an overview.
    Hou T; Xu X
    Curr Pharm Des; 2004; 10(9):1011-33. PubMed ID: 15078130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective optimization of side activities: another way for drug discovery.
    Wermuth CG
    J Med Chem; 2004 Mar; 47(6):1303-14. PubMed ID: 14998318
    [No Abstract]   [Full Text] [Related]  

  • 27. Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leads.
    Edwards PJ; Allart B; Andrews MJ; Clase JA; Menet C
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):425-44. PubMed ID: 16889227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calculation and application of activity discriminants in lead optimization.
    Luo X; Krumrine JR; Shenvi AB; Pierson ME; Bernstein PR
    J Mol Graph Model; 2010 Nov; 29(3):372-81. PubMed ID: 20800520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for the design of RNA-binding small molecules.
    Aboul-ela F
    Future Med Chem; 2010 Jan; 2(1):93-119. PubMed ID: 21426048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA learns from antisense.
    Corey DR
    Nat Chem Biol; 2007 Jan; 3(1):8-11. PubMed ID: 17173018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The search for orally active medications through combinatorial chemistry.
    Fecik RA; Frank KE; Gentry EJ; Menon SR; Mitscher LA; Telikepalli H
    Med Res Rev; 1998 May; 18(3):149-85. PubMed ID: 9578985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicinal chemistry and bioinformatics--current trends in drugs discovery with networks topological indices.
    González-Díaz H; Vilar S; Santana L; Uriarte E
    Curr Top Med Chem; 2007; 7(10):1015-29. PubMed ID: 17508935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational and combinatorial strategies for designing oligonucleotides targeted to RNA structures.
    Toulmé JJ; Le Tinévez R; Boiziau C; Dausse E
    Nucleic Acids Symp Ser; 1997; (36):39-41. PubMed ID: 9478200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved RNA cleavage by LNAzyme derivatives of DNAzymes.
    Vester B; Lundberg LB; Sørensen MD; Babu BR; Douthwaite S; Wengel J
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):37-40. PubMed ID: 14748708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA as a target for drug design, the example of Tat-TAR interaction.
    Froeyen M; Herdewijn P
    Curr Top Med Chem; 2002 Oct; 2(10):1123-45. PubMed ID: 12173971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conserved core substructures in the overlay of protein-ligand complexes.
    Finzel BC; Akavaram R; Ragipindi A; Van Voorst JR; Cahn M; Davis ME; Pokross ME; Sheriff S; Baldwin ET
    J Chem Inf Model; 2011 Aug; 51(8):1931-41. PubMed ID: 21736376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Random molecular fragment methods in computational medicinal chemistry.
    Lounkine E; Batista J; Bajorath J
    Curr Med Chem; 2008; 15(21):2108-21. PubMed ID: 18781938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanding the medicinally relevant chemical space with compound libraries.
    López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
    Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The resurgence of covalent drugs.
    Singh J; Petter RC; Baillie TA; Whitty A
    Nat Rev Drug Discov; 2011 Apr; 10(4):307-17. PubMed ID: 21455239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent solution structures of RNA and its complexes with drugs, peptides and proteins.
    Ramos A; Gubser CC; Varani G
    Curr Opin Struct Biol; 1997 Jun; 7(3):317-23. PubMed ID: 9204272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.